Product Information
DILTIAZEM 12HR ER 90 MG CAP is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.6614 per EA under NDC 68462085101. Its NADAC has been published 286 times since Apr 14, 2021.
FDA first approved this application on Mar 22, 2021. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
90 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462085101
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212317FDA Approved
3/22/2021
TE Code
AB1
On Market Since
3/22/2021
Pharmacological Classes
Price Statistics
The NADAC for DILTIAZEM 12HR ER 90 MG CAP has been published 286 times since Apr 14, 2021, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6614 per EA |
|---|---|
| All-time high | $3.0418 (Apr 12, 2023) |
| All-time low | $1.6614 (Sep 23, 2026) |
| 52-week high | $1.8385 |
| 52-week low | $1.6614 |
| Median price | $2.2416 |
| Average price | $2.2468 |
| Largest weekly change | +31.9% (Feb 22, 2023) |
| Weeks tracked | 286 |
| Tracking since | Apr 14, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diltiazem Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcium Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DILTIAZEM 12HR ER 90 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 12HR ER 90 MG CAP, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.6614 per EA (NDC 68462085101), effective Sep 30, 2026.
How has the price of DILTIAZEM 12HR ER 90 MG CAP changed over time?
Over the history we have for it, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has declined 37.2%. It has been tracked across 286 weekly CMS publications since Apr 14, 2021.
What are the highest and lowest recorded NADAC prices for DILTIAZEM 12HR ER 90 MG CAP?
Since Apr 14, 2021, the NADAC for DILTIAZEM 12HR ER 90 MG CAP has ranged from a low of $1.6614 (Sep 23, 2026) to a high of $3.0418 (Apr 12, 2023), with a median of $2.2416 per EA.
Are there cheaper alternatives to DILTIAZEM 12HR ER 90 MG CAP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DILTIAZEM 12HR ER 90 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DILTIAZEM 12HR ER 90 MG CAP?
DILTIAZEM 12HR ER 90 MG CAP (NDC 68462085101) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.